Hu Y - Search Results

1

Nutlin-1 strengthened anti-proliferation and differentiation-inducing activity of ATRA in ATRA-treated p-glycoprotein deregulated human myelocytic leukemia cells.

Zhang L, Yan Y, Zhu D, Yang W, Wang W, Hu Y, Yang B, He Q. Zhang L, et al. Among authors: hu y. Invest New Drugs. 2012 Feb;30(1):37-47. doi: 10.1007/s10637-010-9512-5. Epub 2010 Aug 5. Invest New Drugs. 2012. PMID: 20686816

2

Efficient activation of p53 pathway in A549 cells exposed to L2, a novel compound targeting p53-MDM2 interaction.

Zhang L, Zhang J, Hu C, Cao J, Zhou X, Hu Y, He Q, Yang B. Zhang L, et al. Among authors: hu c, hu y. Anticancer Drugs. 2009 Jul;20(6):416-24. doi: 10.1097/cad.0b013e32832aa7b0. Anticancer Drugs. 2009. PMID: 19579266

3

Novel combretastatin A-4 derivative XN0502 induces cell cycle arrest and apoptosis in A549 cells.

Zhu H, Zhang J, Xue N, Hu Y, Yang B, He Q. Zhu H, et al. Among authors: hu y. Invest New Drugs. 2010 Aug;28(4):493-501. doi: 10.1007/s10637-010-9424-4. Epub 2010 Mar 30. Invest New Drugs. 2010. PMID: 20352291

4

5k, a novel β-O-demethyl-epipodophyllotoxin analogue, inhibits the proliferation of cancer cells in vitro and in vivo via the induction of G2 arrest and apoptosis.

Xu D, Cao J, Qian S, Li L, Hu C, Weng Q, Lou J, Zhu D, Zhu H, Hu Y, He Q, Yang B. Xu D, et al. Among authors: hu c, hu y. Invest New Drugs. 2011 Oct;29(5):786-99. doi: 10.1007/s10637-010-9423-5. Epub 2010 Mar 30. Invest New Drugs. 2011. PMID: 20352292

5

Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells.

Weng Q, Zhang J, Cao J, Xia Q, Wang D, Hu Y, Sheng R, Wu H, Zhu D, Zhu H, He Q, Yang B. Weng Q, et al. Among authors: hu y. Invest New Drugs. 2011 Dec;29(6):1177-87. doi: 10.1007/s10637-010-9462-y. Epub 2010 Jun 5. Invest New Drugs. 2011. PMID: 20524035

6

Synthesis and hypoxic-cytotoxic activity of some 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.

Jiang F, Yang B, Fan L, He Q, Hu Y. Jiang F, et al. Among authors: hu y. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4209-13. doi: 10.1016/j.bmcl.2006.05.095. Epub 2006 Jun 13. Bioorg Med Chem Lett. 2006. PMID: 16777409

7

MZ3 induces apoptosis in human leukemia cells.

Fang L, He Q, Hu Y, Yang B. Fang L, et al. Among authors: hu y. Cancer Chemother Pharmacol. 2007 Feb;59(3):397-405. doi: 10.1007/s00280-006-0294-6. Epub 2006 Aug 10. Cancer Chemother Pharmacol. 2007. PMID: 16900371

8

Antileukemia activity of MSFTZ-a novel flavanone analog.

He Q, Li R, Fang L, Ying H, Hu Y, Yang B. He Q, et al. Among authors: hu y. Anticancer Drugs. 2006 Jul;17(6):641-7. doi: 10.1097/01.cad.0000215060.70566.59. Anticancer Drugs. 2006. PMID: 16917209

9

Q39, a novel synthetic Quinoxaline 1,4-Di-N-oxide compound with anti-cancer activity in hypoxia.

Weng Q, Wang D, Guo P, Fang L, Hu Y, He Q, Yang B. Weng Q, et al. Among authors: hu y. Eur J Pharmacol. 2008 Mar 10;581(3):262-9. doi: 10.1016/j.ejphar.2007.12.006. Epub 2007 Dec 15. Eur J Pharmacol. 2008. PMID: 18215659

10

MSFTZ, a flavanone derivative, induces human hepatoma cell apoptosis via a reactive oxygen species- and caspase-dependent mitochondrial pathway.

Ying M, Tu C, Ying H, Hu Y, He Q, Yang B. Ying M, et al. Among authors: hu y. J Pharmacol Exp Ther. 2008 Jun;325(3):758-65. doi: 10.1124/jpet.107.135657. Epub 2008 Mar 6. J Pharmacol Exp Ther. 2008. PMID: 18323457

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,001 results

Search Page

Filters